From October 13 to 16, 2021, the "First China (Suzhou) Taihu Pharmaceutical Innovation Conference" hosted by the Wuzhong District People's Government of Suzhou City and undertaken by the Management Committee of Suzhou Wuzhong Economic and Technological Development Zone was held at Suzhou Taihu International Conference Center.
With the theme of "International Pharmaceutical Vision, Global Innovation Pattern", this conference has set up a pharmaceutical leadership summit, and 9 professional sub-forums on drug and medical device innovation and investment. Academicians and scientists at home and abroad, especially many famous clinical research and development experts, chairmen of listed pharmaceutical companies and founders of venture capital institutions were invited to conduct forward-looking, authoritative and predictive exchanges and dialogues on topics such as pharmaceutical industry innovation and investment, and building a collaborative innovation ecosystem, and jointly explore the development path of innovation in the biopharmaceutical industry.
As one of the important members of the Yangtze River Delta Pharmaceutical Innovation Service Alliance, Spectrum Bio and other members jointly witnessed the establishment of the Yangtze River Delta Pharmaceutical Innovation Service Alliance. In the future, the Yangtze River Delta Pharmaceutical Innovation Service Alliance will build an integrated innovation ecosystem under the background of the integration of the Yangtze River Delta, gather high-end resources and share high-end elements for the development of the biopharmaceutical industry, and achieve efficient collaboration and win-win cooperation in the biopharmaceutical industry. We focus on the field of cell and gene therapy drugs, and are committed to enabling more projects to reach the next milestone earlier and faster, bringing more cell and gene therapy drugs to the market, benefiting more patients, and allowing cell drugs to write a new chapter in life.
400-900-1882 
info@hillgene.com 
English
